Pradaxa

A new oral anticoagulant hits the market

Pradaxa gives clinicians a new tool for preventing strokes and
blood clots in patients with atrial fibrillation. Learn how it works,
who’s eligible to receive it, and how to administer it.

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

Get your free subscription to NurseLine!

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.